Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:
Sponsor/Award: Alzheimer's Drug Discovery Foundation - RESEARCH GRANTS - RFP: NOVEL BIOMARKERS ACCELE DRUG DISCOVERY - 2010 FALL COMP

Grant Amount: UP TO $150K FOR ONE YEAR
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: Sep 02, 2010
Sponsor's: Sep 09, 2010

Subject Areas: Biomarkers, Dementia

ADDF funds drug discovery research programs from domestic and international investigators in academia and biotechnology companies.

Drug discovery for frontotemporal dementias (FTD) has been hindered by the heterogeneity of the disease. FTD specific biomarkers that reflect pathological differences are needed to select appropriate patients for clinical trials and monitor target?specific responses to investigational treatments. The Alzheimer?s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) challenge scientists to meet this unmet medical need by submitting applications through this Request for Proposals (RFP).

Application Details: Submission of a Letter of Intent (LOI) is required at least 2 weeks prior to the applications deadline. All applications must be submitted electronically at COSTS ARE NOT SUPPORTED BY THIS PROGRAM
NOTE: Letters of Intent and Full Applications are to be processed through Research Development Services for institutional signatures, and are to be accompanied by a completed RDAF form (bearing applicant, Chair and Dean signatures). Requests for Institutional signatures should be received no less than 3 days prior to the posted Sponsor deadline.
Western Contacts: Pocock,Katy
Russelo,Theresa M

Sponsor Contacts:

1414 Avenue of the Americas
Suite 1502
New York, New York, United States